| A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study JJ Swen, CH van der Wouden, LEN Manson, H Abdullah-Koolmees, ... The Lancet 401 (10374), 347-356, 2023 | 210 | 2023 |
| Economic evaluation in psychiatric pharmacogenomics: a systematic review K Karamperis, M Koromina, P Papantoniou, M Skokou, F Kanellakis, ... The pharmacogenomics journal 21 (4), 533-541, 2021 | 43 | 2021 |
| Genome-based therapeutic interventions for β-type hemoglobinopathies K Karamperis, MT Tsoumpeli, F Kounelis, M Koromina, C Mitropoulou, ... Human Genomics 15 (1), 32, 2021 | 17 | 2021 |
| Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study MI Koufaki, V Fragoulakis, X Díaz-Villamarín, K Karamperis, A Vozikis, ... Human Genomics 17 (1), 51, 2023 | 15 | 2023 |
| Adoption of pharmacogenomic testing: a marketing perspective MI Koufaki, K Karamperis, P Vitsa, K Vasileiou, GP Patrinos, ... Frontiers in pharmacology 12, 724311, 2021 | 10 | 2021 |
| Toward high-throughput fungal electroculturomics and new omics methodologies in 21st-century microbiology and ecology A Stathoulias, A Milioni, S Kritikou, A Karmakolia, S Goudoudaki, ... OMICS: A Journal of Integrative Biology 24 (8), 493-504, 2020 | 9 | 2020 |
| Costing methods as a means to measure the costs of pharmacogenomics testing S Siamoglou, K Karamperis, C Mitropoulou, GP Patrinos The journal of applied laboratory medicine 5 (5), 1005-1016, 2020 | 6 | 2020 |
| Clinical implementation of preemptive pharmacogenomics in psychiatry M Skokou, K Karamperis, MI Koufaki, EE Tsermpini, MT Pandi, ... EBioMedicine 101, 2024 | 5 | 2024 |
| Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients A Stratopoulos, A Kolliopoulou, K Karamperis, A John, K Kydonopoulou, ... Pharmacogenomics 20 (11), 791-801, 2019 | 5 | 2019 |
| Beyond the Microbiome: Germ-ganism? An Integrative Idea for Microbial Existence, Organization, Growth, Pathogenicity, and Therapeutics ME Kambouris, S Goudoudaki, S Kritikou, A Milioni, K Karamperis, ... Omics: A Journal of Integrative Biology 26 (4), 204-217, 2022 | 4 | 2022 |
| Genetic testing K Karamperis, S Wadge, M Koromina, GP Patrinos Applied Genomics and Public Health, 189-207, 2020 | 4 | 2020 |
| Defining genetic-testing delivery and promotional strategies for personalized medicine C Mitropoulou, D Giannouri, K Karamperis, S Wadge, GP Patrinos Applied Genomics and Public Health, 329-344, 2020 | 2 | 2020 |
| Bridging the gap in precision medicine: TranSYS training programme for next-generation scientists L Andreoli, C Berca, S Katz, M Korshevniuk, RM Head, K Van Steen, ... Frontiers in Medicine 11, 1348148, 2024 | | 2024 |
| PREPARE: Η πρώτη Ευρωπαϊκή προοπτική μελέτη εφαρμογής της Φαρμακογονιδιωματικής στην κλινική πράξη ΕΕ Τσερμπίνι, Μ Σκώκου, Κ Καραμπέρης, Σ Σιαμόγλου, Ο Ιβάντσικ, ... Εξατομικευμένη Ιατρική 3 (3), 2021 | | 2021 |
| Systematic review of economic evaluation studies in psychiatric pharmacogenomics. C Mitropoulou, K Karamperis, M Koromina, P Papantoniou, M Skokou, ... European Psychiatry 64, 2021 | | 2021 |
| Μελέτη του ρόλου γενετικών αλλαγών στα γονίδια KLF3 και KLF10 ως φαρμακογονιδιωματικοί βιοδείκτες της απόκρισης ασθενών με Β-τύπου αιμοσφαιρινοπάθειες στην υδροξυουρία Κ Καραμπέρης | | 2018 |
| Correlation of KLF Genomic Variants with Disease Severity and with Hydroxyurea Treatment Efficacy in beta-Hemoglobinopathies Patients A Stratopoulos, A Kolliopoulou, K Karamperis, S Tsekoura, K Tziolia, ... PUBLIC HEALTH GENOMICS 21, 17-17, 2018 | | 2018 |
George P. PatrinosUniversity of Patras, Department of Pharmacy在 upatras.gr 的电子邮件经过验证
